Skip to main content
ARS Home » Plains Area » Kerrville, Texas » Knipling-Bushland U.S. Livestock Insects Research Laboratory » LAPRU » Research » Publications at this Location » Publication #320661

Research Project: Cattle Fever Tick Control and Eradication

Location: Livestock Arthropod Pests Research

Title: Reduced efficacy of commercial acaricides against populations of resistant cattle tick Rhipicephalus microplus from two municipalities of Antioquia, Colombia

Author
item Lopez, Anderson - University Of Antioquia
item Villar, David - University Of Antioquia
item Chaparro, Jenny - University Of Antioquia
item Miller, Robert
item Perez De Leon, Adalberto - Beto

Submitted to: Environmental Health
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: 10/13/2014
Publication Date: 3/19/2015
Publication URL: http://handle.nal.usda.gov/10113/62305
Citation: Lopez, A., Villar, D., Chaparro, J., Miller, R., Perez De Leon, A.A. 2015. Reduced efficacy of commercial acaricides against populations of resistant cattle tick Rhipicephalus microplus from two municipalities of Antioquia, Colombia. Environmental Health. 8(2):71-80.

Interpretive Summary: The southern cattle fever tick, Rhipicephalus (Boophilus) microplus, transmits the microbes that cause the deadly disease bovine babesiosis, and is kept out of the U.S. by the successful execution of the Cattle Fever Tick Eradication Program (CFTEP) administered by USDA-APHIS-VS and the Texas Animal Health Commission. CFTEP personnel inspect and treat infested livestock within a permanent quarantine zone along the Texas-Mexico border to keep the U.S. free of cattle fever ticks. Resistance to products labeled for use to kill ticks, or acaricides, has developed among cattle fever tick populations in several Latin American countries for the past 25 years and outbreaks caused by cattle fever ticks resistant to some acaricides have been reported in the U.S. This paper described the failure of several commercially available acaricides against the southern cattle fever tick in Colombia. Experiments were preformed using several types of acaricides to determine if an acceptable alternative product could be found to control resistant ticks. Unfortunately, none could be found and further research into the extent and magnitude of the resistance in these ticks needs to be conducted. The results of this work benefit the CFTEP and cattle producers in the rest of the Americas impacted by the southern cattle fever tick. Knowledge about the epidemiology of acaricide resistance in Latin American countries can be used by the CFTEP to adapt strategies to eliminate outbreaks in the U.S. caused by acaricide-resistant cattle fever ticks. The cattle industry and consumers save money through the efforts of the CFTEP that keeps the U.S. free of cattle fever ticks and bovine babesiosis.

Technical Abstract: Two distant Antioquian cattle farms where systemic and topical acaricides had previously failed to control infestations by Rhipicephalus (Boophilus) microplus were studied. An initial in vivo study was conducted using single subcutaneous injections with a long-acting formulation of ivermectin (630 µg/kg). Injections were made at 3-month intervals on animals at each farm to evaluate the therapeutic and persistent efficacy of ivermectin against R. microplus. Body tick counts and reproductive parameters of semi- or fully engorged females (=5 mm) were assessed at 10-day intervals, and since no negative control group could be included, values were compared against those for day 0. Although there was an overall reduction of 50%-75% in tick numbers that persisted for 30-40 days, it was not significantly different at one of the farms and not enough to afford protection from severe infestations. The engorgement weight and egg mass weight of ticks from treated animals were significantly lower throughout the 50-day post-treatment period. Egg hatch was not significantly reduced post-treatment and remained at levels of 80%-90%. A random selection of 9 out of 28 commercial formulations of ivermectin sold in Colombia were analyzed by High Performance Liquid Chromatography (HPLC). All were within the expected labeled concentration (±15% deviation) of 1% and 3.15% ivermectin except for one. A popular unregistered injectable widely used in both farms and labeled as "natural pyrethrin", was found to contain 10.5% ivermectin. An adult immersion test was conducted to evaluate the efficacy of topical acaricides to recommended concentrations of five commercial products and/or their combinations. Efficacy was determined by comparing the reproductive index of each treated group to that of the control group. Cypermethrin (150 ppm) was completely ineffective at both farms. Amitraz (208 ppm) exhibited low and intermediate efficacies of 14% and 56%. The combination of amitraz (100 ppm) and cypermethrin (150 ppm) was less efficacious than the amitraz alone. A generic product based on amitraz + citronella (208 ppm + 10 ppm, respectively) was shown to be less efficacious than the name-brand amitraz product. Products containing the organophosphate chlorpyrifos or trichlorfon exhibited intermediate efficacies of approximately 60% at the Tarso farm. We conclude that at these two locations, there is a high degree of resistance to many of the acaricides available in Colombia and confirm suspicions that ivermectin is no longer able to eliminate tick infestations.